Kirsty Duncan on Questions on the Order Paper

With regards to the risk of a pandemic influenza: (a) what steps has the government taken to protect the health of Canadians during the initial delay in the availability of a specific influenza vaccine for the pandemic strain; (b) what human health and economic costs have been identified for Canada for the delay period, and what steps has the government taken to reduce these costs; (c) what is the government stockpile of Tamiflu, and has the government achieved the stockpile target for antivirals and, if not, when will it be reached; and (d) what specific steps has the government taken to address the limited shelf life of Tamiflu, and the development of resistance to the drug?